Cell & Gene Therapy
Specialized quality and regulatory consulting for cell and gene therapy developers and manufacturers.
Overview
Cell and gene therapies bring unique manufacturing, quality, and regulatory challenges — from patient-specific production and living starting materials to complex supply chains and rapidly evolving FDA expectations. Our consultants bring deep experience in advanced therapy manufacturing, including CAR-T, radiopharmaceuticals, and gene-modified cell products across U.S., EU, and APAC markets.
We help organizations build compliant, scalable quality systems and stay inspection-ready at every stage — from early process development through commercial launch and post-market lifecycle management.
Specializations
Key Services
- GMP Compliance for Advanced Therapies
- CAR-T & Cell Therapy Manufacturing Readiness
- Viral Vector & Cell Bank Controls
- Chain of Identity & Chain of Custody
- FDA IND/BLA & Inspection Readiness
- Aseptic Processing & Contamination Control
- Comparability & Process Validation
- Remediation & Warning Letter Support
Ready to Get Started?
Contact us to discuss how we can help with your cell & gene therapy needs.
Schedule ConsultationExplore Other Services
Medical Device & Combination Products
Comprehensive consulting services for medical device and combination product manufacturers.
Learn morePharmaceutical Services
Expert guidance for pharmaceutical companies navigating complex regulatory requirements.
Learn moreBiotech Services
Specialized consulting for biotech organizations developing innovative therapies.
Learn moreReady to Advance Your Compliance Goals?
Partner with Ethagis for expert guidance in regulatory compliance, quality management, and strategic consulting. Let's discuss how we can help your organization succeed.